The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| THC | +23.34% | +610.4% | +48.01% | +9,974% |
| S&P | +14.84% | +96.04% | +14.41% | +6,328% |
Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.
These stocks could attract both value and growth investors.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $5.27B | 3.3% |
| Gross Profit | $852.00M | 27.0% |
| Gross Margin | 16.16% | 3.0% |
| Market Cap | $16.35B | 25.8% |
| Market Cap / Employee | $0.17M | 0.0% |
| Employees | 98K | -8.0% |
| Net Income | $522.00M | 9.4% |
| EBITDA | $1.06B | 20.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.63B | -8.9% |
| Accounts Receivable | $2.57B | -9.8% |
| Inventory | 338 | -11.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $13.09B | 2.5% |
| Short Term Debt | $84.00M | -17.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 5.12% | -4.6% |
| Return On Invested Capital | 6.22% | 3.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $743.00M | 23.4% |
| Operating Free Cash Flow | $936.00M | 25.3% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 5.32 | 3.92 | 8.89 | 11.27 | 131.50% |
| Price to Book | 4.58 | 3.13 | 3.07 | 3.91 | 3.91% |
| Price to Sales | 0.77 | 0.59 | 0.62 | 0.78 | 24.72% |
| Price to Tangible Book Value | -1.82 | -1.48 | -1.62 | -2.04 | 33.82% |
| Price to Free Cash Flow TTM | 6.71 | 10.85 | 9.05 | 10.40 | 50.21% |
| Enterprise Value to EBITDA | 31.89 | 28.68 | 24.77 | 29.49 | -5.68% |
| Free Cash Flow Yield | 14.9% | 9.2% | 11.0% | 9.6% | -33.43% |
| Return on Equity | 118.0% | 110.7% | 38.1% | 41.1% | -64.07% |
| Total Debt | $12.87B | $14.33B | $13.17B | $13.18B | 2.36% |
THC earnings call for the period ending September 30, 2021.
THC earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
